Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #1

    An inside look at Pacific Biosciences technologies...

    The New York Times has a good article on the current technology in use at Pacific Biosciences in Menlo Park.

    http://www.nytimes.com/2008/02/09/bu...gewanted=print

    S.M.R.T. sequencing (Single Molecule Real Time) Sounds like 454 on steroids. Instead of a "picotiter plate" and pyrophosphate detection, these guys are using a "zero mode waveguide" and phospho-linked fluors.

    All I can think of is that old Simpson's episode...

  • sci_guy
    Member
    • Jan 2008
    • 83

    #2
    Amazing stuff! The technology backgrounder is a good document for getting up to speed with SMRT. http://www.pacificbiosciences.com/as...ckgrounder.pdf

    A press release to GenomeWeb today reveals that the machine will be available (if one is optimistic) in 2010. http://www.genomeweb.com/issues/news/144976-1.html

    Comment

    • ECO
      --Site Admin--
      • Oct 2007
      • 1360

      #3
      Here is a link to one of their very recent publications...

      http://www.pnas.org/cgi/content/abstract/105/4/1176

      Comment

      • deepak_bala
        Junior Member
        • Dec 2009
        • 7

        #4
        Here's a link to their animation explaining the process.

        Comment

        • NextGenSeq
          Senior Member
          • Apr 2009
          • 482

          #5
          Thanks for the "unbiased" promotion of PacBio.

          (Note: It might be a good idea to put a disclaimer when you post that you work for them similar to the press releases from the marketing team of companies anticipating to go public.)

          Comment

          • ECO
            --Site Admin--
            • Oct 2007
            • 1360

            #6
            Originally posted by NextGenSeq View Post
            Thanks for the "unbiased" promotion of PacBio.

            (Note: It might be a good idea to put a disclaimer when you post that you work for them similar to the press releases from the marketing team of companies anticipating to go public.)
            Hey there...I assume you're talking to me. This disclaimer has been there since the day I started at PB, and this thread was posted almost a year before I joined.

            Not sure why you keep bringing it up...I've been as open as possible since day one, and if you'd checked the date on this thread before posting what I feel is a pretty snide comment, you'd know that.

            As I said the last time you brought this up, if you would like to start a dialog about my day-job employer and how that may or may not affect the unbiased nature of the site...please do so in the Site Feedback forum and I'll answer any question and consider all opinions.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
              by SEQadmin2




              NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
              Yesterday, 06:46 AM
            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-28-2026, 09:57 AM
            0 responses
            26 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-28-2026, 09:51 AM
            0 responses
            16 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            71 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            48 views
            0 reactions
            Last Post SEQadmin2  
            Working...